polymorphism of LOX and IL6 condition the cardio-vascular events in patients affected by CML receiving TKIs
ATHEROTHROMBOTIC RISK ASSESSMENT DURING TYROSINE KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: NEW INSIGHT?
GALIMBERTI, SARA;
2014-01-01
Abstract
polymorphism of LOX and IL6 condition the cardio-vascular events in patients affected by CML receiving TKIsFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
